TGA approved Resapp, page-31

My question is simple... Don't you think that much of the price of FDA and TGA anticipated approvals is already factored into the share price as it stands (at least 80%)? I base this on the behaviour of the share price with the recent announcements, rising initially to 20c (33%up) and now to 25c (25%up), it does not give me much comfort that the share price is going to rise another 100% to 50-60c on a positive FDA announcement considering that most on here think its almost a fait accompli with Experian group backing us up with a 99%. Surely the most we can hope for is a rise to 30c until commercial deals.